Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies

• Michael Knoflach ,

  * E-mail: michael.knoflach@i-med.ac.at

  Affiliation Department of Neurology, Medical University, Innsbruck, Austria

  ⨯
• Stefan Kiechl,

  Affiliation Department of Neurology, Medical University, Innsbruck, Austria

  ⨯
• Alberto Mantovani,

  Affiliations Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy, Department of Translational Medicine, University of Milan, Milan, Italy

  ⨯
• Ivan Cuccovillo,

  Affiliation Fondazione Humanitas per la Ricerca, Rozzano, Milan, Italy

  ⨯
• Barbara Bottazzi,

  Affiliation Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy

  ⨯
• Qingbo Xu,

  Affiliation Cardiovascular Division, BHF Centre, King's College London, London, United Kingdom

  ⨯
• Qingzhong Xiao,

  Affiliation Cardiovascular Division, BHF Centre, King's College London, London, United Kingdom

  ⨯
• Arno Gasperi,

  Affiliation Department of Neurology, Bruneck Hospital, Bruneck, Italy

  ⨯
• Agnes Mayr,

  Affiliation Department of Laboratory Medicine, Bruneck Hospital, Bruneck, Italy

  ⨯
• Marlene Kehrer,

  Affiliation Department of Internal Medicine, Bruneck Hospital, Bruneck, Italy

  ⨯
• Johann Willeit,

  Affiliation Department of Neurology, Medical University, Innsbruck, Austria

  ⨯
• Georg Wick

  Affiliation Laboratory of Autoimmunity, Biocenter, Innsbruck, Austria

  ⨯